LAB

MKT CAP:$449M

Standard Biotools Inc

Market Cap

$449M

Healthcare·Medical Devices·🇺🇸 United States·NASDAQ

Healthcare·Medical Devices·🇺🇸·NASDAQ

Stock Price

$1.15-$0.12 (-9.45%)

Jun 5, 2026

52W High $1.6852W Low $0.88

Company Details

Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Mi...

CEO

—

IPO Date

Jul 29, 2003

Website

www.standardbio.com

Key Metrics TTM

Revenue

$86M

-35.8% YoY

Net Income

-$94M

EPS (Diluted)

Free Cash Flow

-$94M

Revenue / Share

$0.22

Gross Margin

48.3%

Operating Margin

-91.0%

Net Margin

-109.1%

FCF Margin

-109.5%

P/S

5.2x

P/E

Earnings Reports

Q2 2026

Aug 10, 2026

PENDING

Q1 2026

May 6, 2026

$21M+4.6%

FY 2025

Mar 16, 2026

$85M-51.1%

Q4 2025

Mar 16, 2026

$24M-49.1%

Q3 2025

Nov 4, 2025

$20M-56.5%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee